Pratosartan structure
|
Common Name | Pratosartan | ||
---|---|---|---|---|
CAS Number | 153804-05-8 | Molecular Weight | 426.51400 | |
Density | 1.321g/cm3 | Boiling Point | 692.92ºC at 760 mmHg | |
Molecular Formula | C25H26N6O | Melting Point | N/A | |
MSDS | N/A | Flash Point | 372.864ºC |
Use of PratosartanPratosartan is a selective angiotensin II receptor antagonist. |
Name | pratosartan |
---|---|
Synonym | More Synonyms |
Description | Pratosartan is a selective angiotensin II receptor antagonist. |
---|---|
Related Catalog | |
Target |
angiotensin II receptor[1] |
In Vitro | Pratosartan, which is an orally active angiotensin II (AII) antagonist, exhibiting selective and potent antagonistic activity to AT1 subtype[1]. Pratosartan is a new angiotensin II type 1 receptor blocker. Pratosartan is an effective and well tolerated antihypertensive drug, and may has beneficial effect on hypertensive patients with some metabolic disorders[2]. |
References |
Density | 1.321g/cm3 |
---|---|
Boiling Point | 692.92ºC at 760 mmHg |
Molecular Formula | C25H26N6O |
Molecular Weight | 426.51400 |
Flash Point | 372.864ºC |
Exact Mass | 426.21700 |
PSA | 89.35000 |
LogP | 4.64010 |
Vapour Pressure | 0mmHg at 25°C |
Index of Refraction | 1.701 |
Storage condition | 2-8℃ |
Pratosartan (JAN/INN) |
UNII-66VLQ6E6DL |
2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-5,6,7,8-tetrahydrocyclohepta[d]imidazol-4-one |
KD 3-671 |
KT3-671 |
Pratosartan |